Search Results - "Frontera, Jennifer A."

Refine Results
  1. 1

    Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices by Frontera, Jennifer A., MD, FNCS, Starling, Randall, MD, Cho, Sung-Min, DO, Nowacki, Amy S., PhD, Uchino, Ken, MD, Hussain, M. Shazam, MD, Mountis, Maria, DO, Moazami, Nader, MD

    “…Background Stroke is a major cause of mortality after left ventricular assist device (LVAD) placement. Methods Prospectively collected data of patients with…”
    Get full text
    Journal Article
  2. 2

    Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review by Cho, Sung M., Moazami, Nader, Frontera, Jennifer A.

    Published in Neurocritical care (01-08-2017)
    “…Background Ischemic stroke and intracranial hemorrhage (ICH) following left ventricular assist device (LVAD) placement are major causes of morbidity. The…”
    Get full text
    Journal Article
  3. 3

    COVID‐19 and ischemic stroke by Sagris, Dimitrios, Papanikolaou, Aikaterini, Kvernland, Alexandra, Korompoki, Eleni, Frontera, Jennifer A., Troxel, Andrea B., Gavriatopoulou, Maria, Milionis, Haralampos, Lip, Gregory Y. H., Michel, Patrik, Yaghi, Shadi, Ntaios, George

    Published in European journal of neurology (01-11-2021)
    “…Since the onset of the COVID‐19 pandemic, a substantial proportion of COVID‐19 patients had documented thrombotic complications and ischemic stroke. Several…”
    Get full text
    Journal Article
  4. 4

    Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage by Frontera, Jennifer A., Bhatt, Prachi, Lalchan, Rebecca, Yaghi, Shadi, Ahuja, Tania, Papadopoulos, John, Joset, Danielle

    Published in Journal of thrombosis and thrombolysis (01-01-2020)
    “…Andexanet-alpha is a specific reversal agent for direct factor Xa inhibitors (dFXaI). We aimed to project utilization rates and cost of andexanet for reversal…”
    Get full text
    Journal Article
  5. 5

    Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States by Frontera, Jennifer A, Lewis, Ariane, Melmed, Kara, Lin, Jessica, Kondziella, Daniel, Helbok, Raimund, Yaghi, Shadi, Meropol, Sharon, Wisniewski, Thomas, Balcer, Laura, Galetta, Steven L

    Published in Frontiers in aging neuroscience (19-07-2021)
    “…Little is known regarding the prevalence and predictors of prolonged cognitive and psychological symptoms of COVID-19 among community-dwellers. We aimed to…”
    Get full text
    Journal Article
  6. 6

    Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19 by Valdes, Eduard, Fuchs, Benjamin, Morrison, Chris, Charvet, Leigh, Lewis, Ariane, Thawani, Sujata, Balcer, Laura, Galetta, Steven L., Wisniewski, Thomas, Frontera, Jennifer A.

    Published in Journal of the neurological sciences (15-07-2022)
    “…Persistent cognitive symptoms have been reported following COVID-19 hospitalization. We investigated the relationship between demographics, social determinants…”
    Get full text
    Journal Article
  7. 7

    Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: A prospective, observational study by Frontera, Jennifer A, Thorpe, Lorna E, Simon, Naomi M, de Havenon, Adam, Yaghi, Shadi, Sabadia, Sakinah B, Yang, Dixon, Lewis, Ariane, Melmed, Kara, Balcer, Laura J, Wisniewski, Thomas, Galetta, Steven L

    Published in PloS one (29-09-2022)
    “…Post-acute sequelae of COVID-19 (PASC) includes a heterogeneous group of patients with variable symptomatology, who may respond to different therapeutic…”
    Get full text
    Journal Article
  8. 8

    Editorial: Neurological and Neuroscientific Evidence in Aged COVID-19 Patients by Frontera, Jennifer A, Wisniewski, Thomas

    Published in Frontiers in aging neuroscience (18-10-2021)
    “…While indirect COVID-19 pandemic-related stressors appear to affect a wide age spectrum of the population, the impacts of social isolation, limited access to…”
    Get full text
    Journal Article
  9. 9

    Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States by Ravindra, Vijay M, Grandhi, Ramesh, Delic, Alen, Hohmann, Samuel, Shippey, Ernie, Tirschwell, David, Frontera, Jennifer A, Yaghi, Shadi, Majersik, Jennifer J, Anadani, Mohammad, de Havenon, Adam

    Published in PloS one (14-04-2021)
    “…To examine the outcomes of adult patients with spontaneous intracranial and subarachnoid hemorrhage diagnosed with comorbid COVID-19 infection in a large,…”
    Get full text
    Journal Article
  10. 10

    Impact of medical complications on outcome after subarachnoid hemorrhage by Wartenberg, Katja E, Schmidt, J Michael, Claassen, Jan, Temes, Richard E, Frontera, Jennifer A, Ostapkovich, Noeleen, Parra, Augusto, Connolly, E Sander, Mayer, Stephan A

    Published in Critical care medicine (01-03-2006)
    “…OBJECTIVE:Medical complications occur frequently after subarachnoid hemorrhage (SAH). Their impact on outcome remains poorly defined. DESIGN:Inception cohort…”
    Get full text
    Journal Article
  11. 11

    The National Institutes of Health COVID-19 NeuroDatabank and NeuroBiobank: A National Resource for Learning, Discovery, and Progress by Troxel, Andrea B, Frontera, Jennifer A, Mendoza-Puccini, Carolina

    Published in Frontiers in neurology (15-01-2021)
    “…Patients suffering from COVID-19 experience a wide range of symptoms and sequelae, including increasingly recognized neurological problems. A concerted effort…”
    Get full text
    Journal Article
  12. 12

    Resumption of Anticoagulation After Intracranial Hemorrhage by da Silva, Ivan Rocha Ferreira, Frontera, Jennifer A.

    Published in Current treatment options in neurology (01-11-2017)
    “…Opinion statement Anticoagulation is a vital therapy in a number of different disease processes, and is strongly recommended for the prevention of stroke in…”
    Get full text
    Journal Article
  13. 13

    Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage by Springer, Mellanie V, Schmidt, J Michael, Wartenberg, Katja E, Frontera, Jennifer A, Badjatia, Neeraj, Mayer, Stephan A

    Published in Neurosurgery (01-12-2009)
    “…We sought to determine the frequency, risk factors, and impact on functional outcome and quality of life (QOL) of global cognitive impairment 1 year after…”
    Get full text
    Journal Article
  14. 14

    Neurocritical care complications of pregnancy and puerperum by Frontera, Jennifer A., MD, Ahmed, Wamda, MD

    Published in Journal of critical care (01-12-2014)
    “…Abstract Neurocritical care complications of pregnancy and puerperum such as preeclampsia/eclampsia, hemolysis, elevated liver enzymes, low platelets syndrome,…”
    Get full text
    Journal Article
  15. 15

    Decompressive Hemicraniectomy for Large Hemispheric Strokes by Lin, Jessica, Frontera, Jennifer A.

    Published in Stroke (1970) (01-04-2021)
    “…Large hemispheric infarcts occur in up to 10% of all ischemic strokes and can cause devastating disability. Significant research and clinical efforts have been…”
    Get full text
    Journal Article
  16. 16

    Impact of nosocomial infectious complications after subarachnoid hemorrhage by Frontera, Jennifer A, Fernandez, Andres, Schmidt, J Michael, Claassen, Jan, Wartenberg, Katja E, Badjatia, Neeraj, Parra, Augusto, Connolly, E Sander, Mayer, Stephan A

    Published in Neurosurgery (01-01-2008)
    “…Critically ill neurological patients are susceptible to infections that may be distinct from other intensive care patients. The aim of this study is to…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20